Cargando…

Developing a Gene Biomarker at the Tipping Point of Adaptive and Adverse Responses in Human Bronchial Epithelial Cells

Determining mechanism-based biomarkers that distinguish adaptive and adverse cellular processes is critical to understanding the health effects of environmental exposures. Shifting from in vivo, low-throughput toxicity studies to high-throughput screening (HTS) paradigms and risk assessment based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Currier, Jenna M., Cheng, Wan-Yun, Menendez, Daniel, Conolly, Rory, Chorley, Brian N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873291/
https://www.ncbi.nlm.nih.gov/pubmed/27195669
http://dx.doi.org/10.1371/journal.pone.0155875
_version_ 1782432877917503488
author Currier, Jenna M.
Cheng, Wan-Yun
Menendez, Daniel
Conolly, Rory
Chorley, Brian N.
author_facet Currier, Jenna M.
Cheng, Wan-Yun
Menendez, Daniel
Conolly, Rory
Chorley, Brian N.
author_sort Currier, Jenna M.
collection PubMed
description Determining mechanism-based biomarkers that distinguish adaptive and adverse cellular processes is critical to understanding the health effects of environmental exposures. Shifting from in vivo, low-throughput toxicity studies to high-throughput screening (HTS) paradigms and risk assessment based on in vitro and in silico testing requires utilizing toxicity pathway information to distinguish adverse outcomes from recoverable adaptive events. Little work has focused on oxidative stresses in human airway for the purposes of predicting adverse responses. We hypothesize that early gene expression-mediated molecular changes could be used to delineate adaptive and adverse responses to environmentally-based perturbations. Here, we examined cellular responses of the tracheobronchial airway to zinc (Zn) exposure, a model oxidant. Airway derived BEAS-2B cells exposed to 2–10 μM Zn(2+) elicited concentration- and time-dependent cytotoxicity. Normal, adaptive, and cytotoxic Zn(2+) exposure conditions were determined with traditional apical endpoints, and differences in global gene expression around the tipping point of the responses were used to delineate underlying molecular mechanisms. Bioinformatic analyses of differentially expressed genes indicate early enrichment of stress signaling pathways, including those mediated by the transcription factors p53 and NRF2. After 4 h, 154 genes were differentially expressed (p < 0.01) between the adaptive and cytotoxic Zn(2+) concentrations. Nearly 40% of the biomarker genes were related to the p53 signaling pathway with 30 genes identified as likely direct targets using a database of p53 ChIP-seq studies. Despite similar p53 activation profiles, these data revealed widespread dampening of p53 and NRF2-related genes as early as 4 h after exposure at higher, unrecoverable Zn(2+) exposures. Thus, in our model early increased activation of stress response pathways indicated a recoverable adaptive event. Overall, this study highlights the importance of characterizing molecular mechanisms around the tipping point of adverse responses to better inform HTS paradigms.
format Online
Article
Text
id pubmed-4873291
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48732912016-06-09 Developing a Gene Biomarker at the Tipping Point of Adaptive and Adverse Responses in Human Bronchial Epithelial Cells Currier, Jenna M. Cheng, Wan-Yun Menendez, Daniel Conolly, Rory Chorley, Brian N. PLoS One Research Article Determining mechanism-based biomarkers that distinguish adaptive and adverse cellular processes is critical to understanding the health effects of environmental exposures. Shifting from in vivo, low-throughput toxicity studies to high-throughput screening (HTS) paradigms and risk assessment based on in vitro and in silico testing requires utilizing toxicity pathway information to distinguish adverse outcomes from recoverable adaptive events. Little work has focused on oxidative stresses in human airway for the purposes of predicting adverse responses. We hypothesize that early gene expression-mediated molecular changes could be used to delineate adaptive and adverse responses to environmentally-based perturbations. Here, we examined cellular responses of the tracheobronchial airway to zinc (Zn) exposure, a model oxidant. Airway derived BEAS-2B cells exposed to 2–10 μM Zn(2+) elicited concentration- and time-dependent cytotoxicity. Normal, adaptive, and cytotoxic Zn(2+) exposure conditions were determined with traditional apical endpoints, and differences in global gene expression around the tipping point of the responses were used to delineate underlying molecular mechanisms. Bioinformatic analyses of differentially expressed genes indicate early enrichment of stress signaling pathways, including those mediated by the transcription factors p53 and NRF2. After 4 h, 154 genes were differentially expressed (p < 0.01) between the adaptive and cytotoxic Zn(2+) concentrations. Nearly 40% of the biomarker genes were related to the p53 signaling pathway with 30 genes identified as likely direct targets using a database of p53 ChIP-seq studies. Despite similar p53 activation profiles, these data revealed widespread dampening of p53 and NRF2-related genes as early as 4 h after exposure at higher, unrecoverable Zn(2+) exposures. Thus, in our model early increased activation of stress response pathways indicated a recoverable adaptive event. Overall, this study highlights the importance of characterizing molecular mechanisms around the tipping point of adverse responses to better inform HTS paradigms. Public Library of Science 2016-05-19 /pmc/articles/PMC4873291/ /pubmed/27195669 http://dx.doi.org/10.1371/journal.pone.0155875 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Currier, Jenna M.
Cheng, Wan-Yun
Menendez, Daniel
Conolly, Rory
Chorley, Brian N.
Developing a Gene Biomarker at the Tipping Point of Adaptive and Adverse Responses in Human Bronchial Epithelial Cells
title Developing a Gene Biomarker at the Tipping Point of Adaptive and Adverse Responses in Human Bronchial Epithelial Cells
title_full Developing a Gene Biomarker at the Tipping Point of Adaptive and Adverse Responses in Human Bronchial Epithelial Cells
title_fullStr Developing a Gene Biomarker at the Tipping Point of Adaptive and Adverse Responses in Human Bronchial Epithelial Cells
title_full_unstemmed Developing a Gene Biomarker at the Tipping Point of Adaptive and Adverse Responses in Human Bronchial Epithelial Cells
title_short Developing a Gene Biomarker at the Tipping Point of Adaptive and Adverse Responses in Human Bronchial Epithelial Cells
title_sort developing a gene biomarker at the tipping point of adaptive and adverse responses in human bronchial epithelial cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873291/
https://www.ncbi.nlm.nih.gov/pubmed/27195669
http://dx.doi.org/10.1371/journal.pone.0155875
work_keys_str_mv AT currierjennam developingagenebiomarkeratthetippingpointofadaptiveandadverseresponsesinhumanbronchialepithelialcells
AT chengwanyun developingagenebiomarkeratthetippingpointofadaptiveandadverseresponsesinhumanbronchialepithelialcells
AT menendezdaniel developingagenebiomarkeratthetippingpointofadaptiveandadverseresponsesinhumanbronchialepithelialcells
AT conollyrory developingagenebiomarkeratthetippingpointofadaptiveandadverseresponsesinhumanbronchialepithelialcells
AT chorleybriann developingagenebiomarkeratthetippingpointofadaptiveandadverseresponsesinhumanbronchialepithelialcells